Filing Flows › Comparisons › HCWB vs SER
HCW Biologics vs Serina Therapeutics: HCWB and SER compared
HCW Biologics is the larger company: $136K of revenue in its latest quarter (Q2 2026) against $130K for Serina Therapeutics (Q2 2025). HCW Biologics is growing faster (21× against +155% a year earlier).
Where the money goes: HCWB and SER
HCW Biologics (HCWB) · Q2 2026
HCW Biologics, Q2 2026: revenue $136K (21× year over year), net loss $5.2M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
Serina Therapeutics (SER) · Q2 2025
Serina Therapeutics, Q2 2025: revenue $130K (+155% year over year), net loss $6.5M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.
| HCW Biologics (HCWB) | Serina Therapeutics (SER) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2025 |
| Revenue | $136K | $130K |
| Revenue growth, Y/Y | 21× | +155% |
| Operating margin | n/m | n/m |
| Net earnings | −$5.2M | −$6.5M |
| Operating cash flow | −$4.0M | −$3.8M |
Questions
Which is bigger, HCW Biologics or Serina Therapeutics?
HCW Biologics is the larger company: $136K of revenue in its latest quarter (Q2 2026) against $130K for Serina Therapeutics (Q2 2025).
Is HCW Biologics or Serina Therapeutics growing faster?
HCW Biologics is growing faster (21× against +155% a year earlier).
More: HCW Biologics earnings · how HCW Biologics makes money · Serina Therapeutics earnings · how Serina Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 11, 2025). Fiscal quarters can end on different dates. Not investment advice.